American International Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-40,540
| Closed | -$301K | – | 817 |
|
|
2024
Q1 | $301K | Sell |
40,540
-349
| -0.9% | -$2.9K | ﹤0.01% | 1914 |
|
|
2023
Q4 | $414K | Sell |
40,889
-165
| -0.4% | -$1.45K | ﹤0.01% | 1783 |
|
|
2023
Q3 | $320K | Buy |
41,054
+7,546
| +23% | +$64.7K | ﹤0.01% | 1858 |
|
|
2023
Q2 | $276K | Buy |
33,508
+165
| +0.5% | +$1.44K | ﹤0.01% | 1991 |
|
|
2023
Q1 | $242K | Buy |
33,343
+664
| +2% | +$5.9K | ﹤0.01% | 2010 |
|
|
2022
Q4 | $290K | Sell |
32,679
-119
| -0.4% | -$1.31K | ﹤0.01% | 1918 |
|
|
2022
Q3 | $401K | Buy |
32,798
+463
| +1% | +$7.21K | ﹤0.01% | 1712 |
|
|
2022
Q2 | $383K | Sell |
32,335
-1,620
| -5% | -$21.7K | ﹤0.01% | 1783 |
|
|
2022
Q1 | $646K | Sell |
33,955
-2,390
| -7% | -$44.4K | ﹤0.01% | 1584 |
|
|
2021
Q4 | $965K | Sell |
36,345
-1,087
| -3% | -$37.4K | ﹤0.01% | 1452 |
|
|
2021
Q3 | $1.54M | Sell |
37,432
-889
| -2% | -$48.7K | 0.01% | 1177 |
|
|
2021
Q2 | $2.17K | Sell |
38,321
-587
| -2% | -$21.7K | 0.01% | 1085 |
|
|
2021
Q1 | $1.63K | Buy |
38,908
+2,399
| +7% | +$137K | 0.01% | 1218 |
|
|
2020
Q4 | $2.56K | Sell |
36,509
-1,047
| -3% | -$43K | 0.01% | 990 |
|
|
2020
Q3 | $1.05M | Buy |
37,556
+3,632
| +11% | +$118K | 0.01% | 1224 |
|
|
2020
Q2 | $1M | Buy |
33,924
+3,303
| +11% | +$86.3K | ﹤0.01% | 1223 |
|
|
2020
Q1 | $607K | Sell |
30,621
-1,768
| -5% | -$44.6K | ﹤0.01% | 1336 |
|
|
2019
Q4 | $959K | Buy |
32,389
+1,050
| +3% | +$26.2K | ﹤0.01% | 1354 |
|
|
2019
Q3 | $713K | Sell |
31,339
-217
| -0.7% | -$5.38K | ﹤0.01% | 1488 |
|
|
2019
Q2 | $781K | Buy |
31,556
+2,076
| +7% | +$49.6K | ﹤0.01% | 1454 |
|
|
2019
Q1 | $721K | Sell |
29,480
-955
| -3% | -$21.6K | ﹤0.01% | 1503 |
|
|
2018
Q4 | $692K | Buy |
30,435
+154
| +0.5% | +$4.19K | ﹤0.01% | 1483 |
|
|
2018
Q3 | $964K | Buy |
30,281
+546
| +2% | +$17.6K | ﹤0.01% | 1466 |
|
|
2018
Q2 | $1.06M | Buy |
29,735
+6,025
| +25% | +$213K | ﹤0.01% | 1345 |
|
|
2018
Q1 | $786K | Buy |
23,710
+511
| +2% | +$18.2K | ﹤0.01% | 1418 |
|
|
2017
Q4 | $713K | Buy |
23,199
+534
| +2% | +$13.4K | ﹤0.01% | 1570 |
|
|
2017
Q3 | $544K | Buy |
22,665
+1,695
| +8% | +$32.3K | ﹤0.01% | 1715 |
|
|
2017
Q2 | $352K | Buy |
20,970
+16,739
| +396% | +$302K | ﹤0.01% | 1933 |
|
|
2017
Q1 | $94K | Buy |
4,231
+281
| +7% | +$5.82K | ﹤0.01% | 2625 |
|
|
2016
Q4 | $64K | Sell |
3,950
-11
| -0.3% | -$167 | ﹤0.01% | 2794 |
|
|
2016
Q3 | $53.4K | Buy |
3,961
+6
| +0.2% | +$123 | ﹤0.01% | 2882 |
|
|
2016
Q2 | $96.5K | Buy |
+3,955
| New | +$133K | ﹤0.01% | 2628 |
|
Other funds holding EDIT
DTC
WP
American International Group's EDIT Position: Q2 2024 in Review
American International Group sold out of Editas Medicine (EDIT) in Q2 2024, closing a stake of 40,540 shares — an estimated $301K sold.
American International Group first reported a position in EDIT in Q2 2016 and held it in 32 quarters. The position peaked at $1.54M in Q3 2021. 235 funds tracked by Wall St. Rank hold EDIT as of Q2 2024.
- American International Group reported no remaining Editas Medicine position as of Q2 2024 after selling out during the quarter.
- American International Group sold 40,540 Editas Medicine shares in Q2 2024, an estimated $301K.
- American International Group first reported a position in Editas Medicine in Q2 2016 and held it in 32 quarters.
- American International Group's Editas Medicine position peaked at $1.54M in Q3 2021.
- 235 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.